All dollar amounts stated herein are in U.S. dollars unless specified otherwise. Overview We are a pharmaceutical company developing a pipeline of proprietary small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. CB1 and CB2 receptors are each part of the endocannabinoid system that is found throughout the human body and is responsible for many homeostatic functions. CB1 receptors ...
Q2 FY2026 — expected 2026-09-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-09-23 | 2025-06-30 | 0001213900-25-090210 | EDGAR | 75K words |
| 2024-09-30 | 2024-06-30 | 0001213900-24-082843 | EDGAR | — |
| 2023-09-29 | 2023-06-30 | 0001213900-23-080842 | EDGAR | — |
| 2022-09-23 | 2022-06-30 | 0001213900-22-058355 | EDGAR | — |
| 2021-09-24 | 2021-06-30 | 0001213900-21-049679 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-11 | 2025-12-31 | 0001213900-26-014996 | EDGAR | 22K words |
| 2025-11-06 | 2025-09-30 | 0001213900-25-107152 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001213900-25-042126 | EDGAR | — |
| 2025-02-12 | 2024-12-31 | 0001213900-25-013063 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001213900-24-098445 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001213900-24-042467 | EDGAR | — |
| 2024-02-13 | 2023-12-31 | 0001213900-24-013414 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001213900-23-086255 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039477 | EDGAR | — |
| 2023-02-17 | 2022-12-31 | 0001213900-23-012859 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001213900-22-071487 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001213900-22-026136 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-22 | 0001213900-26-080414 | EDGAR | — |
| 2026-04-03 | 0001213900-26-039943 | EDGAR | 1K words |
| 2026-03-30 | 0001062993-26-001697 | EDGAR | — |
| 2026-03-23 | 0001062993-26-001567 | EDGAR | — |
| 2026-03-09 | 0001062993-26-001347 | EDGAR | — |
| 2026-03-06 | 0001213900-26-024752 | EDGAR | — |
| 2026-02-12 | 0001062993-26-000819 | EDGAR | — |
| 2025-12-18 | 0001062993-25-017390 | EDGAR | — |
| 2025-12-15 | 0001213900-25-121497 | EDGAR | — |
| 2025-11-19 | 0001213900-25-112644 | EDGAR | — |
218 total filings indexed. 191 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001728328 |
| Ticker | INM |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | A1 |
| Website | https://www.inmedpharma.com |
| Listed | 2020-11-10 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/INM (~200 tokens, structured JSON with cryptographic provenance)